CD53 and metabolic dysfunction-associated steatotic liver disease: Yet, whether CD53 mechanistically participates in the adaptive metabolic effects, which we previously demonstrated in GLUT8-deficient mice (e.g., protection from NAFLD and insulin resistance (32, 33, 38, 44, 53, 70, 71, 72)), remains to be fully determined.